Natixis Advisors’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-421,811
Closed -$633K 1450
2022
Q3
$633K Buy
421,811
+29,844
+8% +$61.3K ﹤0.01% 1226
2022
Q2
$886K Sell
391,967
-23,997
-6% -$69.6K ﹤0.01% 1152
2022
Q1
$1.42M Buy
415,964
+63,365
+18% +$344K 0.01% 1048
2021
Q4
$2.61M Buy
352,599
+43,765
+14% +$318K 0.01% 874
2021
Q3
$2.48M Buy
308,834
+110,971
+56% +$1.08M 0.01% 861
2021
Q2
$2.45M Buy
+197,863
New +$2.35M 0.01% 849

Other funds holding AVAH

Natixis Advisors's AVAH Position: Q4 2022 in Review

Natixis Advisors sold out of Aveanna Healthcare (AVAH) in Q4 2022, closing a stake of 421,811 shares — an estimated $633K sold.

Natixis Advisors first reported a position in AVAH in Q2 2021 and held it in 6 quarters. The position peaked at $2.61M in Q4 2021. 81 funds tracked by Wall St. Rank hold AVAH as of Q4 2022.

  • Natixis Advisors reported no remaining Aveanna Healthcare position as of Q4 2022 after selling out during the quarter.
  • Natixis Advisors sold 421,811 Aveanna Healthcare shares in Q4 2022, an estimated $633K.
  • Natixis Advisors first reported a position in Aveanna Healthcare in Q2 2021 and held it in 6 quarters.
  • Natixis Advisors's Aveanna Healthcare position peaked at $2.61M in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q4 2022.

Based on Natixis Advisors's 13F filing for Q4 2022, filed 27 Jan 2023.